SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Emmaus Life Sciences, Inc. – ‘10-Q’ for 3/31/18 – ‘EX-10.7’

On:  Monday, 5/14/18, at 5:22pm ET   ·   For:  3/31/18   ·   Accession #:  1615774-18-3746   ·   File #:  1-35527

Previous ‘10-Q’:  ‘10-Q’ on 2/20/18 for 12/31/17   ·   Next:  ‘10-Q’ on 8/10/18 for 6/30/18   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/14/18  Emmaus Life Sciences, Inc.        10-Q        3/31/18   65:4.9M                                   S2 Filings LLC/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    436K 
 2: EX-3.2      Articles of Incorporation/Organization or Bylaws    HTML     48K 
 3: EX-10.3     Material Contract                                   HTML     55K 
 4: EX-10.4     Material Contract                                   HTML     28K 
 5: EX-10.5     Material Contract                                   HTML     22K 
 6: EX-10.6     Material Contract                                   HTML     21K 
 7: EX-10.7     Material Contract                                   HTML     22K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     23K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
17: R1          Document and Entity Information                     HTML     45K 
18: R2          Unaudited Condensed Consolidated Balance Sheets     HTML    112K 
19: R3          Unaudited Condensed Consolidated Balance Sheets     HTML     43K 
                (Parenthetical)                                                  
20: R4          Unaudited Condensed Consolidated Statements of      HTML     62K 
                Operations                                                       
21: R5          Unaudited Condensed Consolidated Statements of      HTML     95K 
                Cash Flows                                                       
22: R6          Organization, Nature of Operations and Going        HTML     34K 
                Concern Uncertainty                                              
23: R7          Summary of Significant Accounting Policies          HTML     83K 
24: R8          Accounts Receivable                                 HTML     25K 
25: R9          Long - Term Borrowings and Other Note Payables      HTML     25K 
26: R10         Acquisition                                         HTML     55K 
27: R11         Stockholders' Equity                                HTML    150K 
28: R12         Convertible Preferred Stock                         HTML     36K 
29: R13         Income Taxes                                        HTML     27K 
30: R14         Related Party Transactions                          HTML     24K 
31: R15         Loss Per Share                                      HTML     39K 
32: R16         Commitments and Contingent Liabilities              HTML     33K 
33: R17         Subsequent Events                                   HTML     30K 
34: R18         Summary of Significant Accounting Policies          HTML    144K 
                (Policies)                                                       
35: R19         Summary of Significant Accounting Policies          HTML     30K 
                (Tables)                                                         
36: R20         Accounts Receivable (Tables)                        HTML     25K 
37: R21         Acquisition (Tables)                                HTML     49K 
38: R22         Stockholders' Equity (Tables)                       HTML    101K 
39: R23         Loss Per Share (Tables)                             HTML     37K 
40: R24         Organization, Nature of Operations and Going        HTML     38K 
                Concern Uncertainty (Details Narrative)                          
41: R25         Summary of Significant Accounting Policies          HTML     24K 
                (Details)                                                        
42: R26         Summary of Significant Accounting Policies          HTML     32K 
                (Details 1)                                                      
43: R27         Summary of Significant Accounting Policies          HTML     70K 
                (Details Narrative)                                              
44: R28         Accounts Receivable (Details)                       HTML     26K 
45: R29         Long - Term Borrowings and Other Note Payables      HTML     45K 
                (Details Narrative)                                              
46: R30         Acquisition (Details)                               HTML     65K 
47: R31         Acquisition (Details 1)                             HTML     27K 
48: R32         Acquisition (Details Narrative)                     HTML     52K 
49: R33         Stockholders' Equity (Details)                      HTML     30K 
50: R34         Stockholders' Equity (Details 1)                    HTML     25K 
51: R35         Stockholders' Equity (Details 2)                    HTML     52K 
52: R36         Stockholders' Equity (Details 3)                    HTML     38K 
53: R37         Stockholders' Equity (Details 4)                    HTML     31K 
54: R38         Stockholders' Equity (Details 5)                    HTML     54K 
55: R39         Stockholders' Equity (Details Narrative)            HTML    401K 
56: R40         Stockholders' Equity (Details Narrative 1)          HTML     69K 
57: R41         Convertible Preferred Stock (Details Narrative)     HTML     56K 
58: R42         Income Taxes (Details Narrative)                    HTML     36K 
59: R43         Related Party Transactions (Details Narrative)      HTML     33K 
60: R44         Loss Per Share (Details)                            HTML     40K 
61: R45         Commitments and Contingent Liabilities (Details     HTML     71K 
                Narrative)                                                       
62: R46         Subsequent Events (Details Narrative)               HTML     58K 
64: XML         IDEA XML File -- Filing Summary                      XML    105K 
63: EXCEL       IDEA Workbook of Financial Reports                  XLSX     86K 
11: EX-101.INS  XBRL Instance -- mynd-20180331                       XML   1.36M 
13: EX-101.CAL  XBRL Calculations -- mynd-20180331_cal               XML    153K 
14: EX-101.DEF  XBRL Definitions -- mynd-20180331_def                XML    643K 
15: EX-101.LAB  XBRL Labels -- mynd-20180331_lab                     XML    960K 
16: EX-101.PRE  XBRL Presentations -- mynd-20180331_pre              XML    808K 
12: EX-101.SCH  XBRL Schema -- mynd-20180331                         XSD    140K 
65: ZIP         XBRL Zipped Folder -- 0001615774-18-003746-xbrl      Zip    147K 


‘EX-10.7’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 10.7 

 

AMENDMENT TO AGREEMENT

 

This Amendment to Agreement (“Amendment”) is made by and between MYnd Analytics, Inc. (hereinafter “MYnd”) and George C. Carpenter, IV (hereinafter “Employee”) is effective as of the last date set forth below (the “Effective Date”).

 

On or about September 7, 2007, Employee and Mynd entered into the above Agreement for at will employment.

 

The parties agree that the Agreement will be amended as follows: Mr. Carpenter’s annual salary will be reduced from $270,000 to $206,250. Further, upon the effective date of this Amendment, Mr. Carpenter is granted either 34,380 shares of common or an option to purchase 56,000 shares of common stock at the Employee’s option. The shares or options will vest quarterly. If the Employee’s relationship with the Company is terminated, the above grant will be pro-rated. The parties agree to review this modification on or before December 31, 2018.

 

Except as expressly modified by this Amendment, the Agreement shall be and remain in full force and effect in accordance with its terms and shall constitute the legal, valid, binding and enforceable obligations to the parties. This Amendment and the Agreement (including any written amendments thereto), collectively, are the complete agreement of the parties and supersede any prior agreements or representations, whether oral or written, with respect thereto.

 

Agreed and Accepted:

 

Date: April 13, 2018   Date: April 19, 2018
         
Employee   MYnd Analytics, Inc.
         
By: /s/ George Carpenter   By: /s/ Don D’Ambrosio
  George Carpenter     Don D’Ambroso, CFO

 

X 34,380 shares

  

    56,000 options of common stock

 

 C: 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
12/31/1810-Q
Filed on:5/14/18
4/19/184
4/13/18
For Period end:3/31/18
9/7/07
 List all Filings 
Top
Filing Submission 0001615774-18-003746   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., Apr. 24, 6:52:58.1pm ET